Skip to Content

Brain Bubble

A new drug-delivery device may offer new hope to patients afflicted with glioma-a type of brain tumor that is now invariably fatal. University of Kentucky neuroscientist Roy Patchell has invented a device, called Serodur, that directly administers therapeutic drugs to the tumor. Serodur consists of a silicon bubble implanted under the scalp and a tube that carries drugs from this chamber to the tumor through a flow-regulating membrane. Serodur can be refilled by injecting more medicine through the scalp into the reservoir. Such direct injection allows for a higher dosage and fewer side effects than conventional intravenous chemotherapy, says Patchell. And with its direct line into the brain, Serodur can dispense drugs that are unable to cross the so-called “blood-brain barrier “-including drugs that selectively kill dividing cancerous cells in order to destroy the tumor more effectively. Patchell expects a large-scale national trial of the device to begin next year.

Keep Reading

Most Popular

A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?

Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.

A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate

Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.

10 Breakthrough Technologies 2023

Every year, we pick the 10 technologies that matter the most right now. We look for advances that will have a big impact on our lives and break down why they matter.

These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway

Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.